Pfizer Announces Positive Results from Interim Breast Cancer Trial
1 day ago / Read about 0 minute
Author:小编   

Pfizer Inc. announced that its experimental breast cancer drug, atirmociclib, has achieved its primary objectives in an interim clinical trial, marking significant progress in its oncology pipeline.